VeriMomSollte ich retinoyl tetrapeptide-43 amide in der Schwangerschaft meiden? | VeriMom
No harmonised CLP reproductive classification (no entry in ECHA Annex VI) and no CIR or SCCS safety assessment found for this specific ingredient (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, CosIng, PubChem). However, the molecule contains a retinoyl (retinoid) moiety, which is a structural/class-based theoretical concern for developmental toxicity; there are no animal or human reproductive data for this specific peptide to elevate the hazard score. Topical peptide with large molecular weight and amide linkage suggests negligible systemic absorption under typical cosmetic use (hence exposure scored 0).
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Ist retinoyl tetrapeptide-43 amide in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (no entry in ECHA Annex VI) and no CIR or SCCS safety assessment found for this specific ingredient (sources searched: ECHA Annex VI, CIR, SCCS, PubMed, CosIng, PubChem). However, the molecule contains a retinoyl (retinoid) moiety, which is a structural/class-based theoretical concern for developmental toxicity; there are no animal or human reproductive data for this specific peptide to elevate the hazard score. Topical peptide with large molecular weight and amide linkage suggests negligible systemic absorption under typical cosmetic use (hence exposure scored 0).
- Ist retinoyl tetrapeptide-43 amide während des Stillens sicher?
- Same rationale as pregnancy: theoretical class-based concern due to retinoyl group but no specific reproductive or lactation transfer data. No regulatory harmonised flags or CIR/SCCS opinion for this ingredient. Expected topical absorption negligible, so low likelihood of significant transfer into breastmilk absent data.
- Ist retinoyl tetrapeptide-43 amide sicher für Babyhaut?
- Hazard and mechanism remain theoretical (retinoid moiety) with no infant-specific data. Exposure increased by +1 relative to adult because infant skin has higher permeability and surface-area-to-weight, and although adult topical absorption is expected negligible, infant exposure is considered low but measurable in absence of definitive absorption data.
- Wie bewertet VeriMom retinoyl tetrapeptide-43 amide?
- VeriMom bewertet retinoyl tetrapeptide-43 amide mit 13/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu retinoyl tetrapeptide-43 amide?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu retinoyl tetrapeptide-43 amide basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.